Quest Diagnostics Inventory

Quest Diagnostics (DGX) currently reports a inventory of $230M as of June 2026. That compares with $190M in the prior-year period — up 24.6% year over year. Use the charts on this page to explore Quest Diagnostics's inventory history and peer comparisons.

Quest Diagnostics's inventory increased from $190M to $230M — a 24.6% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Quest Diagnostics reported $230M in inventory as of June 2026. That compares with $190M in the prior-year period — up 24.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current inventory of $230M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Quest Diagnostics, and consider following DGX for alerts when major investors trade the stock.

Quest Diagnostics is classified in the Healthcare sector. On inventory, it currently shows $230M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing DGX with unrelated industries.